| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |